Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Light & Wonder Q1 2026 Earnings Call - Recurring Revenue Engine Offsets SciPlay Softness and Macro Headwinds
Light & Wonder delivered a quarter defined by structural resilience rather than headline growth. Consolidated revenue rose 2% year-over-year, but the real story lies in the quality of that revenue. Re...
- Recurring revenue dominance: Recurring revenue now represents 73% of consolidated revenue, growing 13% year-over-year, reinforcing the quality and durability of the earnings base.
- Cash flow surge: Adjusted free cash flow jumped 86% year-over-year to $207 million, driven by favorable timing of receivables, lower tax payments, and the cash-generative nature of the shifting revenue mix.
- Margin expansion across the board: EBITDA margins expanded year-over-year across every business segment, with Gaming margins reaching 53% due to a richer mix of recurring revenue units and strong game performance.
- +9 more takeaways
Zillow Group Q1 2026 Earnings Call - Rentals Revenue Surges 42% While AI and Integration Drive Margin Expansion
Zillow Group delivered a quarter of relentless execution, posting 18% revenue growth to $708 million and EBITDA of $182 million, effectively decoupling from a flat housing market. The standout story i...
- Total revenue grew 18% year-over-year to $708 million, landing near the high end of the outlook range, proving the business can scale despite a flat housing market.
- EBITDA came in at $182 million, exceeding guidance, driven by lower legal and people costs than anticipated, resulting in a 26% EBITDA margin.
- Net income reached $46 million with a net income margin expansion of over 500 basis points year-over-year, signaling strong operational leverage.
- +12 more takeaways
Navigator Holdings Q1 2026 Earnings Call - Record Net Income Driven by Ethylene Terminal Surge and Geopolitical Tailwinds
Navigator Holdings reported a record first quarter of 2026, posting net income of $36 million, or $0.55 per share, a milestone driven by resilient trading, strategic asset sales, and unprecedented dem...
- Navigator Holdings delivered record net income of $36 million ($0.55 per share) in Q1 2026, marking the highest quarterly earnings in the company's history.
- The Morgan's Point ethylene export terminal achieved record throughput of over 300,000 tons in Q1, a 57% increase from Q4 2025 and more than 2.5 times the volume from Q1 2025.
- Geopolitical disruptions in the Middle East, specifically the closure of the Strait of Hormuz, have created significant commercial tailwinds by forcing global buyers to shift toward U.S. ethylene and ethane exports.
- +7 more takeaways
NVE Corporation Q4 FY2026 Earnings Call - Non-Defense Sales Surge 34% as Defense Revenue Dips and Capacity Doubles
NVE Corporation delivered a sharp rebound in its non-defense business during Q4 FY2026, with product sales jumping 34% year-over-year to offset a steep 79% decline in defense revenue. The company repo...
- Non-defense product sales surged 34% year-over-year in Q4, driving a 27% increase in net income to $4.9 million or $1.02 per diluted share.
- Total revenue rose 5% to $7.65 million, with product sales up 6% offset by a 19% decline in contract R&D revenue.
- Defense product sales plummeted 79% year-over-year, but management expects a significant recovery in defense sales for fiscal 2027.
- +7 more takeaways
Kratos Defense & Security Solutions Q1 2026 Earnings Call - Record Backlog and Margin Expansion Signals Defense Industrial Base Rebuild
Kratos Defense & Security Solutions delivered a strong start to 2026, with Q1 revenue of $371 million significantly beating estimates and organic growth accelerating across unmanned systems, turbine t...
- Q1 2026 revenue reached $371 million, exceeding the high end of the $335–345 million estimate and reflecting 15.8% organic growth.
- The company reported a record backlog of $2 billion and an opportunity pipeline exceeding $14 billion, with a 1.6:1 overall book-to-bill ratio and a 3:1 ratio specifically in satellite communications.
- Unmanned Systems revenue grew 30.9% organically, driven by Valkyrie program activity and tactical drone awards, while Turbine Technologies saw 20.3% organic growth.
- +7 more takeaways
Tarsus Pharmaceuticals Q1 2026 Earnings Call - XDEMVY Sales Surge 85% as ECPs Expand Treatment Beyond Classic Demodex Cases
Tarsus Pharmaceuticals delivered another quarter of exceptional momentum with XDEMVY net product sales jumping 85% year-over-year to $145.4 million. The growth is no longer just about launch velocity....
- XDEMVY net product sales reached $145.4 million in Q1 2026, an 85% year-over-year increase, driven by deeper prescribing and a widening patient funnel.
- Eye care physicians are expanding treatment beyond classic Demodex blepharitis cases, now screening and treating patients with keratoconus, chalazia, and preoperative cataract conditions.
- Retreatment rates have climbed to the mid-teens and are expected to stabilize at approximately 20% of total prescriptions at steady state.
- +7 more takeaways
Herbalife Ltd. Q1 2026 Earnings Call - Personalized Nutrition Push Drives Strong India Growth and Record Sales
Herbalife delivered a robust start to 2026, with first quarter net sales rising 7.8% year-over-year to $1.3 billion and adjusted EBITDA hitting $176 million, both exceeding guidance. The results were ...
- Net sales reached $1.3 billion, up 7.8% year-over-year and 5.4% on a constant currency basis, marking the third consecutive quarter of growth and beating the high end of guidance.
- India delivered record quarterly net sales of $275 million, driven by a 32% year-over-year increase, fueled by strong demand following a September 2025 GST rate reduction.
- Adjusted EBITDA came in at $176 million, above the $175 million high end of guidance, with an adjusted EBITDA margin of 13.3%.
- +7 more takeaways
electroCore Q1 2026 Earnings Call - Revenue Surges 43% as VA Penetration and Consumer Efficiency Drive Operating Leverage
electroCore delivered its strongest quarter to date, with revenue jumping 43% year-over-year to $9.6 million. Gross margins expanded to 87%, and adjusted EBITDA losses narrowed by 24%, signaling clear...
- Record Q1 revenue of $9.6 million, up 43% year-over-year, driven by 48% growth in prescription device sales within the VA system.
- Gross margin expanded 200 basis points to 87%, with adjusted EBITDA loss narrowing 24% to $2.3 million, demonstrating clear operating leverage.
- Quell Fibromyalgia surpassed $1 million in quarterly revenue for the first time, adding to cumulative VA sales of $2.5 million since acquisition.
- +7 more takeaways
Axon Enterprise Q1 2026 Earnings Call - AI Era Plan Drives 140% Bookings Surge and Dedrone Scales Beyond Expectations
Axon Enterprise delivered a record first quarter, with revenue climbing 34% year-over-year to $807 million and software and services growing 35% to $355 million. The standout driver was the Axon AI Er...
- Revenue reached $807 million, up 34% year-over-year, marking the ninth consecutive quarter of growth above 30%
- Software and services revenue grew 35% to $355 million, with AI product revenue surging more than 700% year-over-year
- Future contracted bookings hit a record $14.3 billion, up 44% year-over-year, driven by broad-based demand across all markets
- +7 more takeaways
Alpha Teknova Q1 2026 Earnings Call - Clinical Solutions Surge and 2027 Growth Ambitions
Alpha Teknova delivered a solid Q1 2026 with revenue up 13% year-over-year to $11.2 million, driven by an 85% surge in Clinical Solutions revenue. The company is shifting from cash conservation to str...
- Q1 2026 revenue grew 13% year-over-year to $11.2 million, the first Q1 in nearly three years to exceed $11 million.
- Clinical Solutions revenue surged 85% to $2.1 million, driven by broader customer base and higher average order values.
- Lab Essentials revenue stabilized at $8.4 million, up 3%, with higher revenue per customer offsetting a decline in active customer count.
- +7 more takeaways